Filing Flows › agilon health (AGL) › Q3 2026 › vs Q3 2025
agilon health (AGL) Q3 2026 vs Q3 2025 (year over year)
agilon health's revenue rose $84.2M (+6%) from $1.4B in Q3 2025 to $1.5B in Q3 2026. Operating margin 1.6% against -9.1% (+10.7 pts).
agilon health, Q3 2026: revenue $1.5B (+6% year over year), operating margin 1.6%, net earnings $34.9M, operating cash flow $49.9M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Operating margin | 1.6% | -9.1% | +10.7 pts |
| Net margin | 2.3% | -7.7% | +10.0 pts |
| Free cash flow margin | 3.1% | -1.5% | +4.6 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $1.5B | $1.4B | $84.2M | +6% |
| Other income, net | $14.8M | $20.7M | −$5.9M | -29% |
| Operating profit | $24.1M | −$131M | $155M | — |
| Costs & expenses | $1.5B | $1.6B | −$71.2M | -5% |
| Pre-tax earnings | $38.9M | −$111M | $149M | — |
| General & admin | $67.1M | $56.2M | $10.9M | +19% |
| Other operating costs | $1.4B | $1.5B | −$82.2M | -5% |
| Net earnings | $34.9M | −$110M | $145M | — |
| Income tax | $4.0M | −$331K | $4.3M | — |
| Depreciation & amortization | $6.7M | $7.4M | −$689K | -9% |
| Share-based compensation | $18.9M | $7.5M | $11.4M | +152% |
| Working capital & other | $10.6M | −$77.1M | $87.8M | — |
| Operating cash flow | $49.9M | −$18.2M | $68.0M | — |
| Free cash flow (OCF − capex) | $46.6M | −$21.3M | $67.9M | — |
| Capital expenditures | $3.3M | $3.2M | $82K | +3% |
Questions
How much did agilon health's revenue grow year over year in Q3 2026?
agilon health's revenue rose $84.2M (+6%) from $1.4B in Q3 2025 to $1.5B in Q3 2026. Operating margin 1.6% against -9.1% (+10.7 pts).